BIOTECanada is pleased to announce Bio+ech Connec+, a unique forum for early-stage Canadian biotech companies to connect directly with the business development and investment leaders of multinational pharma/biotech companies.

The next Bio+ech Connec+ will take place on Wednesday, March 16th featuring Merck.

This virtual forum will include a plenary session led by Lizabeth Leveille, Vice President, Business Development & Licensing, Head, Boston & European Innovation Hubs & Discovery Transactions, and Marwan Akar, President & Managing Director – Merck Canada providing an overview of the company, its R&D priorities including its pipeline and corresponding investment priorities for the period ahead.

Merck representatives will then engage in a Q&A session with the plenary audience. Following the plenary and Q&A, a select group of early-stage companies will be provided an opportunity to connect bilaterally with the Merck representatives.

Bilateral Meetings with Merck

If you would like to participate in a 30-minute one-on-one meeting session with Merck representatives following the plenary, please apply by Wednesday, March 2nd. You will be notified if you have secured a meeting by Thursday, March 10th. (The application process is quick and painless!).  APPLY HERE 

Note: Plenary and Q&A will run approx. 1:00-2:00 PM. Your 30-min meeting will occur at some point after 2:00 PM (ET) in the afternoon of March 16th.